Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry

Etienne Puymirat,Romain Didier,Hélène Eltchaninoff,Bernard lung,Jean-Philippe Collet,Dominique Himbert,Eric Durand,Alain Leguerrier,Pascal Leprince,Jean Fajadet,Emmanuel Teiger,Karine Chevreul,Michel Lievre,Didier Tchetche,Florence Leclercq,Stephan Chassaing,Hervé Le Breton,Patrick Donzeau-Gouge,Thierry Lefèvre,Didier Carrié,Martine Gillard,Didier Blanchard

Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry

2017

Background Coronary artery disease (CAD) is common in patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of CAD distribution before TAVR on short‐ and long‐term prognosis remains unclear.

Keywords:

Cardiology
Diabetes mellitus
Internal medicine
Aortic valve replacement
Coronary artery disease
Medicine
Percutaneous coronary intervention
Population
Artery
Hazard ratio
Confidence interval
Valve replacement
Revascularization

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations